HBK Investments’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-4,809
Closed -$2.26M 355
2023
Q2
$2.26M Buy
+4,809
New +$2.02M 0.01% 197
2021
Q1
Sell
-31,888
Closed -$5.38M 994
2020
Q4
$5.38M Sell
31,888
-3,829
-11% -$572K 0.04% 259
2020
Q3
$5.29M Buy
35,717
+3,800
+12% +$588K 0.04% 213
2020
Q2
$5.24M Buy
+31,917
New +$4.9M 0.07% 183
2020
Q1
Sell
-19,542
Closed -$2.57M 293
2019
Q4
$2.57M Sell
19,542
-59,950
-75% -$6.95M 0.02% 386
2019
Q3
$8.89M Sell
79,492
-52,700
-40% -$5.87M 0.11% 135
2019
Q2
$14.6M Buy
132,192
+60,734
+85% +$7.15M 0.13% 71
2019
Q1
$9.27M Buy
71,458
+7,245
+11% +$881K 0.09% 180
2018
Q4
$7.43M Buy
+64,213
New +$7.17M 0.08% 201
2018
Q3
Sell
-43,409
Closed -$3.7M 1272
2018
Q2
$3.7M Sell
43,409
-178,773
-80% -$14.7M 0.02% 333
2018
Q1
$17.2M Buy
222,182
+176,382
+385% +$14.2M 0.12% 97
2017
Q4
$3.87M Buy
45,800
+26,202
+134% +$2.23M 0.03% 309
2017
Q3
$1.68M Sell
19,598
-13,874
-41% -$1.14M 0.01% 492
2017
Q2
$2.75M Buy
+33,472
New +$2.73M 0.02% 349
2016
Q3
Sell
-91,084
Closed -$7.17M 924
2016
Q2
$7.17M Buy
91,084
+25,584
+39% +$1.93M 0.05% 200
2016
Q1
$4.72M Buy
+65,500
New +$4.96M 0.05% 277
2013
Q4
Sell
-330,900
Closed -$16.7M 956
2013
Q3
$16.7M Buy
+330,900
New +$17.3M 0.24% 52

Other funds holding LLY

HBK Investments's LLY Position: Q3 2023 in Review

HBK Investments sold out of Eli Lilly (LLY) in Q3 2023, closing a stake of 4,809 shares — an estimated $2.26M sold.

HBK Investments first reported a position in LLY in Q3 2013 and held it in 17 quarters. The position peaked at $17.2M in Q1 2018. 2,974 funds tracked by Wall St. Rank hold LLY as of Q3 2023.

  • HBK Investments reported no remaining Eli Lilly position as of Q3 2023 after selling out during the quarter.
  • HBK Investments sold 4,809 Eli Lilly shares in Q3 2023, an estimated $2.26M.
  • HBK Investments first reported a position in Eli Lilly in Q3 2013 and held it in 17 quarters.
  • HBK Investments's Eli Lilly position peaked at $17.2M in Q1 2018.
  • 2,974 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2023.

Based on HBK Investments's 13F filing for Q3 2023, filed 14 Nov 2023.